🇺🇸 FDA
Pipeline program

Esketamine

KY20251118-09

Unknown small_molecule active

Quick answer

Esketamine for Post Induction Hypotension is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Post Induction Hypotension
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials